
Cefotaxime + Water for injection
1 vial and 1 ampoule
Group of action
Active ingredient
Dosage form
Powder for solution for injections
ATC code
J01D D01
RX/OTC
RX
Marketing authorisation no.
UA/13415/01/01
General properties
Pharmacotherapeutic group
Antibacterial agents for system usage. Beta-lactam antibiotics. Third generation cephalosporins.
Indications
Infections caused by the drug susceptible microorganisms:
- infections of ENT-organs (tonsillitis, otitis);
- respiratory tract infections (bronchitis, pneumonia, pleuritis, abscess);
- urinary tract infections;
- septemia, bacteriemia;
- intra-abdominal infections (including peritonitis);
- skin and soft tissue infections;
- bone and joint infections;
- meningitis (except listeric) and other CNS-related infections.
Infection prevention after surgical interventions to digestive tracts, urological and obstetric-gynecologic surgeries.
Contraindications
Hypersensitivity to cephalosporins, lidocaine (if lidocaine is used as a solvent), and to other b-lactam antibiotics in anamnesis; haemorrhage, enterocolitis in anamnesis (in particular, nonspecific ulcerative colitis), АV-block without integrated cardiac pacemaker, severe cardiac failure.
Pharmaceutical characteristics
Basic physical and chemical properties
Crystalline powder from near-white to light yellow color.
Shelf life
2 years.
By prescription.
Manufacturer
JSC "Lekhim-Kharkiv".
Location
36, Severyna Pototskoho St., 61115 Kharkiv, Ukraine.